These findings reveal a novel mechanism by which circVAPA promotes HCC cell proliferation through the miR-377-3p/PSAP axis and provide potential biomarkers and therapeutic targets aimed at treating HCC (Figure 6). The gene discussed is PSAP; the disease is hepatocellular carcinoma.